Skip to main content

RDY 354 Pill - orange capsule/oblong, 17mm

Pill with imprint RDY 354 is Orange, Capsule/Oblong and has been identified as Rivastigmine Tartrate 4.5 mg. It is supplied by Dr. Reddy's Laboratories Ltd.

Rivastigmine is used in the treatment of Alzheimer's Disease; Parkinson's Disease and belongs to the drug class cholinesterase inhibitors. There is no proven risk in humans during pregnancy. Rivastigmine 4.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for RDY 354

Rivastigmine tartrate 4.5 mg RDY 354
Rivastigmine tartrate 4.5 mg RDY 354

Rivastigmine Tartrate

Imprint
RDY 354
Strength
4.5 mg
Color
Orange
Size
17.00 mm
Shape
Capsule/Oblong
Availability
Prescription only
Drug Class
Cholinesterase inhibitors
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Dr. Reddy's Laboratories Ltd.
National Drug Code (NDC)
55111-0354
Inactive Ingredients
silicon dioxide, hypromellose 2910 (5 mPa.s), magnesium stearate, microcrystalline cellulose, gelatin, titanium dioxide, ferrosoferric oxide, ferric oxide red, ferric oxide yellow

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.